News Focus
News Focus
Followers 35
Posts 8894
Boards Moderated 1
Alias Born 04/04/2020

Re: Whalatane post# 263771

Tuesday, 04/07/2020 9:38:34 PM

Tuesday, April 07, 2020 9:38:34 PM

Post# of 448124
Kiwi, thanks for getting back to me. Backing Teva in the US would make sense in the event of losing the appeal. Royalty payments are better than nothing. I would think we could also amend our settlement agreement with Teva to get them to market possible ahead of the generics we are in court with. Winning the court battle in this situation is not the point. ( in my opinion.) Money is the point. Backing Teva would be one more way we could stop the other generic companies from making money. If we can see this then I assume all the lawyers involved can see this. This situation is very different then our FDA battle from year's ago. Amarin and the generic companies both have something to gain by reaching an agreement, and everything to loose by fighting. I have been invested here since before the original adcom. Reading your posts ever since. Nice to actually talk to you.
Sleven.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News